It is unusual for the term infant to develop sepsis in the absence of maternal or fetal risk factors, because most infection appearing in the early neonatal period is the result of chorioamnionitis. These risk factors include prolonged rupture of membranes for Ͼ18 to 24 hours, cloudy or malodorous amniotic fluid, signs of peripartum infection (fever, uterine tenderness, maternal tachycardia, and/or leukocytosis), history of fetal tachycardia, and laboratory evidence of maternal vaginal colonization with group B streptococci. 2, 4 The presence of one or more risk factors in asymptomatic newborns is an indication for obtaining laboratory data.
Laboratory Studies
Laboratory data (see Table 1 ) that have been used to diagnose neonatal sepsis include the complete white blood cell count (WBC) and differential, the immature to total neutrophil (I/T) ratio, and the c-reactive protein (CRP). 4 -6 There are several reasons, however, why interpretation of these tests is problematic. These tests have large individual variation in this age group. Furthermore, the gestational age, postnatal age, and activity of the infant may affect the test results at the time of sampling. For example, arterial samples generally have a lower WBC than capillary samples, and vigorously crying newborns may have a falsely elevated WBC. 6 Both neutropenia (a WBC of Ͻ5000/mm 3 ) and neutrophilia (a WBC of Ͼ30,000/mm 3 ) have been associated with neonatal sepsis. However, neutropenia has a positive predictive value of only 27% 1, 7 and is also observed for noninfectious conditions such as maternal hypertension, severe asphyxia, and periventricular hemorrhage. 1 The differential count of the WBC, which provides an estimate of the percentages of the types of mature and immature white blood cells present in the peripheral blood, has been used to improve the usefulness of the WBC. The aforementioned sampling differences also significantly affect the percentage of immature cells estimated. In addition, although the differential count gives point estimates of the real percentage of cells of given types at the moment of counting, it is actually representative of a range of estimates. 8 The WBC and differential are especially unreliable predictors of sepsis in the first 24 hours of life. 3 A more sensitive index that may also be derived from the differential WBC is the I/T ratio. Although this has been recommended as the single test needed to identify infected infants, the result may also be normal in the septic newborn, especially if the sample is drawn within the first 24 hours of life. 9 The normal maximum reference value for the I/T ratio during the first day of life is 0.16, 10 but investigators have reported I/T ratios of Ն0.22 in noninfected infants with other illnesses.
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The CRP has also been used to diagnose neonatal sepsis. This single test has low sensitivity and may be elevated in noninfectious conditions such as meconium aspiration, respiratory distress, and intracranial hemorrhage. 12 The CRP may be increased in 8% to 9% of apparently healthy newborns. Moreover, increased CRP levels associated with bacterial infections may not be evident until 12 to 24 hours after the appearance of clinical signs, 13 making CRP less useful in the
initial evaluation of the at-risk neonate. Sepsis screens employing various combinations of laboratory tests have been used in an attempt to improve reliability. 3, 7, 9 One study reports a hematologic scoring system that was developed in an attempt to improve the diagnostic accuracy of the complete WBC. 3 In this study a score of 1 was assigned for each abnormal finding of the following seven laboratory studies: total leukocyte count, total neutrophil count, immature neutrophil count, I/T ratio, immature to mature neutrophil ratio, platelet count, and degenerative morphologic changes in polymorphonuclear cells. A score of Ն3 had a sensitivity of 96% with a positive predictive value of 58%, which was better than the most reliable single test, the I/T ratio. Another study assessed the effectiveness of a sepsis screen consisting of five components: I/T ratio, leukocyte count, latex CRP, erythrocyte sedimentation rate, and latex haptoglobin. 7 The most significant finding of this study was that "the probability that sepsis is not present with less than two tests positive is more than 99%." However, these tests were performed at the bedside, which may pose reproducibility problems in other institutions.
Although serial determinations of various laboratory tests intuitively seem of more diagnostic value than single determinations, few reports of sepsis screens using serial laboratory data are available. One study examined the efficacy of sequential laboratory and clinical evaluations in the identification of infected neonates born to mothers treated with intrapartum antibiotic therapy.
14 During sequential evaluation, 82% of at-risk infants with normal laboratory tests remained asymptomatic, whereas the remaining 18% developed either clinical or laboratory signs of sepsis and were diagnosed as proven or presumed sepsis. The equivalent of the I/T ratio (percent band to percent polymorphonuclear cell ratio) was significantly higher at birth in the group of infants that were subsequently treated for proven and/or presumed sepsis when compared with at-risk noninfected infants ( p Ͻ 0.001). Increased sensitivity is also noted with serial CRP determinations, which have proven to be valuable in establishing the diagnosis, monitoring the disease course, and determining the appropriate length of antibiotic therapy. 4, 5 A persistent increase in CRP at 48 hours after birth is highly suggestive of infection.
The blood culture, which was formerly the most relied on test for the diagnosis of sepsis, recently has been shown to be problematic. In one study, nearly 50% of the neonatal deaths caused by infection were diagnosed by the postmortem blood culture with negative premortem cultures. 15 Although the use of blood cultures from multiple sites may improve the usefulness of this test, multiple site cultures provided additive information in only 3.9% of cases in a recent study.

ANTIBIOTIC THERAPY
Maternal antibiotics have been recommended for the treatment of maternal chorioamnionitis to reduce the incidence and severity of neonatal sepsis. 16, 17 This practice has been shown to decrease the incidence of culture-proven neonatal bacteremia. 18 Unfortunately, it may also result in a concomitant decrease in the sensitivity of the blood cultures drawn from the at-risk neonate. Maternal antibiotic therapy has been reported to sterilize the blood cultures in infected offspring without eradicating serious infections such as pneumonia and meningitis, 19 which usually develop as the result of bacteremia. 4 †Remainder of data obtained during the first 3 days of life from both term and preterm infants. 5 Consensus as to when to initiate antibiotic therapy in the asymptomatic high-risk newborn has not been reached. A survey of neonatal and pediatric infectious disease fellowship directors confirmed the disparity in the management strategies for asymptomatic term neonates born to mothers treated with intrapartum antibiotics. 20 A total of 39% of survey responders preferred to initiate antibiotic therapy empirically. Other survey responders preferred initiating antibiotic therapy if laboratory data were abnormal. Most recently, the Committee on Fetus and Newborn of the American Academy of Pediatrics has made recommendations for the management of infants born to mothers who received intrapartum antibiotics for prevention of early onset group B streptococcal disease based on the number of antibiotic doses received before delivery and gestational age. 21 Asymptomatic at-risk infants who are Ն35 weeks whose mothers have received Ն2 doses of penicillin before delivery need not be treated with antibiotic therapy.
LAC؉USC WCH PROTOCOL
Physicians at LACϩUSC WCH have developed the following strategy to reduce the risk of both overtreatment of noninfected infants and nontreatment of infected infants (see Figure 1) . This strategy employs a combination of serial laboratory studies and observation as the method of sepsis screening for this high-risk population. Term and nearterm infants with the maternal or fetal risk factors for sepsis outlined previously are evaluated with a blood culture; in addition, complete WBC with differential and CRP studies are done within 2 hours of birth. The LACϩUSC WCH protocol uses laboratory tests that should be quickly available in most institutions and therefore suitable for employment as a sepsis screen. Laboratory studies are repeated at 12-to 24-hour intervals according to the following protocol: (1) All infants who develop signs and symptoms of sepsis are transferred to the neonatal intensive care unit for antibiotic therapy and supportive care given at the discretion of the attending neonatologist; (2) asymptomatic infants with borderline laboratory values (I/T ratios of 0.12 to 0.2, band counts of 10% to 24%, or CRP of 1 to 3 mg/dl) have repeat studies performed at 24-hour intervals; (3) asymptomatic infants with normal laboratory studies (a WBC of 5,000 to 30,000/mm 3 , I/T ratios of Ͻ0.12, band counts of Ͻ10%, and CRP of Ͻ3 mg/dl) are observed for signs and symptoms of sepsis for 48 hours; (4) asymptomatic infants with two of five laboratory criteria (a WBC of Ͼ30,000/ mm 3 or Ͻ5,000/mm 3 , I/T ratios of Ͼ0.2, band counts of Ͼ24%, CRP of Ͼ3 mg/dl, and/or positive blood cultures) are transferred to the neonatal intensive care unit for further care. The initiation of antibiotic therapy is left to the discretion of the attending neonatologist, who may opt to continue close observation and repeat laboratory studies and/or initiate antibiotic therapy for varying lengths of time depending on the infant's clinical course and on the trend of laboratory data.
Implementation of the protocol appears to allow safe management of asymptomatic at-risk infants in the term nursery without putting these infants at increased risk for morbidity and mortality secondary to undertreatment and overwhelming infection. 22 From July 1, 1995 to August 31, 1995, we evaluated 110 term or nearterm (birth weight of Ն2250 gm and/or gestational age of Ն35 weeks) at-risk infants admitted to our nurseries at LACϩUSC WCH following the above protocol. Maternal antibiotics were given before delivery in 57% of the cases studied. Although blood cultures in all 110 infants were negative, 11% (12 of 110) of the infants developed symptoms consistent with sepsis. Seven of these symptomatic infants were given antibiotics, whereas the remaining five were thought to have symptoms more consistent with other diagnoses and were observed in the neonatal intensive care unit with repeated lab tests. Of the 36 treated infants, 31 remained asymptomatic but were treated following abnormal laboratory studies. A total of 62 of the 110 infants (56%) could be followed after discharge (see Table 2 ). One asymptomatic infant with abnormal laboratory values was treated for 7 days in the nursery but returned within 3 days with serious disease and suspected sepsis. One asymptomatic infant with normal laboratory values was discharged at 48 hours and returned 12 hours later with symptoms of sepsis. This infant responded well to antibiotic therapy. A total of 60 of 62 infants (97%) were healthy at follow-up.
No single laboratory test has been demonstrated to be sufficiently accurate to identify infected infants early in the disease course. Therefore management strategies involving the use of sepsis screens that use two or more laboratory tests appear to be the most efficient diagnostic approach for identifying neonatal sepsis.
There is no agreement in the literature as to the length of observation necessary for asymptomatic at-risk newborns. Forty-eight hours has been established as the minimum time necessary for observation and/or laboratory evaluation of the at-risk infant at LACϩUSC WCH. This is consistent with the previously mentioned recommendations by the American Academy of Pediatrics for observation of infants of mothers who received intrapartum antimicrobial prophylaxis for prevention of group B streptococcal disease.
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CONCLUSION
The management strategy used at LACϩUSC WCH since 1995 is a rational approach to the problems associated with management of asymptomatic infants at risk for sepsis. During the study period in 1995, 10% of the fullterm and nearterm infants born at LACϩUSC WCH were at risk for sepsis. Of the 6129 neonates born at LACϩUSC WCH during 1995, an estimated 613 neonates were at risk. If all atrisk infants were treated with at least 3 days of antibiotic therapy, 552 of 613 infants would have been overtreated, putting them at substantially greater risk for antibiotic resistance, pain, maternal separation, and increased health related costs to their families. The data presented from the pilot study of these high-risk infants done at LACϩUSC WCH in 1995 indicate that these infants may be safely observed with decreased use of antibiotic therapy. A randomized prospective study (multicentered is desirable) of the management of term and nearterm neonates at risk for sepsis will be needed to confirm the safety of this approach. The data of interest, especially in this era of maternal intrapartum antibiotic therapy, are the incidence of neonatal sepsis (both culture-proven and presumed), the time frame required for the development of signs of sepsis, and the incidence of hospital readmission following discharge from the newborn nursery. Such a study should illustrate the optimum observation period for high-risk infants and the optimum duration of antibiotic therapy and should serve to determine the most efficacious protocol for management of this population.
